Skip to content

Aptus Capital Advisors, LLC: ISCV position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Aptus Capital Advisors, LLC on ISCV, newest first. How the timeline and the estimate are built.

Aptus Capital Advisors, LLC held 60,183 ISCV shares at 2026-06-30 per its 13F-HR filed 2026-08-12.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 60,183 shares
    Change vs previous 13F +2,883 shares

    0.03% of the 13F portfolio, value $4,713,442.

    13F-HR 0001398344-26-014189 filed by Aptus Capital Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 57,300 shares
    Change vs previous 13F +1,527 shares

    0.03% of the 13F portfolio, value $3,982,923.

    13F-HR 0001398344-26-008931 filed by Aptus Capital Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 55,773 shares
    Change vs previous 13F +4,691 shares

    0.03% of the 13F portfolio, value $3,820,451.

    13F-HR 0001398344-26-003004 filed by Aptus Capital Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 51,082 shares
    Change vs previous 13F +33,753 shares

    0.03% of the 13F portfolio, value $3,404,002.

    13F-HR 0001398344-25-020792 filed by Aptus Capital Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 17,329 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $1,063,800.

    13F-HR 0001398344-25-014888 filed by Aptus Capital Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).